Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRADIMED CORPIRMD · Entity 4896 | Director · CEO, President, Chairman · 10% owner | June 01, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRADIMED CORP
Report date June 01, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,164,600 |
Reported balance
After 2026-06-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-06-01 · Sale · Disposed 400 · Balance 2,164,600 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2: This transaction was executed in multiple trades at prices ranging from $88.10 to $88.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,163,825 |
Reported balance
After 2026-06-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-01 · Sale · Disposed 775 · Balance 2,163,825 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3: This transaction was executed in multiple trades at prices ranging from $89.29 to $90.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,163,424 |
Reported balance
After 2026-06-01 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-06-01 · Sale · Disposed 401 · Balance 2,163,424 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4: This transaction was executed in multiple trades at prices ranging from $90.69 to $91.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,162,500 |
Reported balance
After 2026-06-01 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-06-01 · Sale · Disposed 924 · Balance 2,162,500 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5: This transaction was executed in multiple trades at prices ranging from $91.75 to $92.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Roger E. Susi Revocable Trust | 162,950 |
Reported balance
Holding disclosure · report date 2026-06-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 162,950 |
| Common StockSEC Table I · non-derivative | IndirectBy Matthew Susi 2008 Dynasty Trust | 2,062,500 |
Reported balance
Holding disclosure · report date 2026-06-01 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 2,062,500 F6: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
F2: This transaction was executed in multiple trades at prices ranging from $88.10 to $88.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $89.29 to $90.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $90.69 to $91.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $91.75 to $92.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2026 Filed Apr 1, 2026 19:35 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,497 | $95.66 | $143,203.02 |
DisclosureSEC source: 0001613801-26-000020 · wk-form4_1775072117.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,225,155 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $95.40 to $96.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 19:35 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 5,848 | $94.81 | $554,448.88 |
DisclosureSEC source: 0001613801-26-000020 · wk-form4_1775072117.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,226,652 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $94.36 to $95.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2026 Filed Mar 25, 2026 20:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 915 | $100.71 | $92,149.65 |
DisclosureSEC source: 0001613801-26-000018 · form4-03252026_040301.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,232,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $100.53 to $100.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2026 Filed Mar 25, 2026 20:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,585 | $100.03 | $158,547.55 |
DisclosureSEC source: 0001613801-26-000018 · form4-03252026_040301.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,233,415 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $99.49 to $100.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 23, 2026 Filed Mar 25, 2026 20:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,300 | $102.02 | $132,626.00 |
DisclosureSEC source: 0001613801-26-000018 · form4-03252026_040301.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,235,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $102.00 to $102.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 23, 2026 Filed Mar 25, 2026 20:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 750 | $100.70 | $75,525.00 |
DisclosureSEC source: 0001613801-26-000018 · form4-03252026_040301.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,236,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $100.05 to $100.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 23, 2026 Filed Mar 25, 2026 20:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,950 | $99.58 | $293,761.00 |
DisclosureSEC source: 0001613801-26-000018 · form4-03252026_040301.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,237,050 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $99.02 to $100.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 18:10 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,500 | $102.43 | $256,075.00 |
DisclosureSEC source: 0001613801-26-000016 · form4-03182026_060343.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,240,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $102.06 to $102.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 18:10 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,991 | $101.68 | $202,444.88 |
DisclosureSEC source: 0001613801-26-000016 · form4-03182026_060343.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,242,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $101.38 to $101.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 18:10 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,009 | $101.18 | $304,450.62 |
DisclosureSEC source: 0001613801-26-000016 · form4-03182026_060343.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,244,491 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.37 to $101.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 10, 2026 Filed Mar 10, 2026 20:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,500 | $100.11 | $250,275.00 |
DisclosureSEC source: 0001613801-26-000014 · form4-03102026_040301.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,247,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $100.00 to $100.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 20:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 5,000 | $100.04 | $500,200.00 |
DisclosureSEC source: 0001613801-26-000014 · form4-03102026_040301.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,250,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.00 to $100.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,200 | $99.12 | $118,944.00 |
DisclosureSEC source: 0001613801-26-000012 · form4-03092026_040305.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,255,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $99.01 to $99.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 6,300 | $98.25 | $618,975.00 |
DisclosureSEC source: 0001613801-26-000012 · form4-03092026_040305.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,256,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $98.00 to $99.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 661 | $101.38 | $67,012.18 |
DisclosureSEC source: 0001613801-26-000008 · form4-01272026_050101.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,262,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $101.14 to $101.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,339 | $100.54 | $436,243.06 |
DisclosureSEC source: 0001613801-26-000008 · form4-01272026_050101.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,263,161 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.05 to $100.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,797 | $102.70 | $184,551.90 |
DisclosureSEC source: 0001613801-26-000006 · form4-01212026_040101.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,267,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $102.62 to $102.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,074 | $102.03 | $109,580.22 |
DisclosureSEC source: 0001613801-26-000006 · form4-01212026_040101.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,269,297 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $101.56 to $102.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,129 | $101.03 | $215,092.87 |
DisclosureSEC source: 0001613801-26-000006 · form4-01212026_040101.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,270,371 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.50 to $101.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2026 Filed Jan 13, 2026 21:20 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 112 | $98.15 | $10,992.80 |
DisclosureSEC source: 0001613801-26-000004 · form4-01132026_040101.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,272,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $98.11 to $98.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2026 Filed Jan 13, 2026 21:20 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,888 | $97.43 | $476,237.84 |
DisclosureSEC source: 0001613801-26-000004 · form4-01132026_040101.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,272,612 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $96.94 to $97.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 754 | $99.48 | $75,007.92 |
DisclosureSEC source: 0001613801-26-000002 · form4-01062026_040101.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,277,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $99.41 to $99.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,209 | $98.42 | $217,409.78 |
DisclosureSEC source: 0001613801-26-000002 · form4-01062026_040101.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,278,254 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $98.12 to $98.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 883 | $97.52 | $86,110.16 |
DisclosureSEC source: 0001613801-26-000002 · form4-01062026_040101.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,280,463 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $97.09 to $98.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 300 | $95.58 | $28,674.00 |
DisclosureSEC source: 0001613801-26-000002 · form4-01062026_040101.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,281,346 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 854 | $95.10 | $81,215.40 |
DisclosureSEC source: 0001613801-26-000002 · form4-01062026_040101.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,281,646 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $94.55 to $95.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 101 | $98.31 | $9,929.31 |
DisclosureSEC source: 0001613801-25-000042 · form4-12302025_041230.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,282,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $98.17 to $98.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,899 | $97.65 | $478,387.35 |
DisclosureSEC source: 0001613801-25-000042 · form4-12302025_041230.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,282,601 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $97.15 to $98.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 22, 2025 Filed Dec 22, 2025 21:10 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,228 | $97.70 | $119,975.60 |
DisclosureSEC source: 0001613801-25-000040 · form4-12222025_041201.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,287,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $97.36 to $98.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 22, 2025 Filed Dec 22, 2025 21:10 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,772 | $96.42 | $363,696.24 |
DisclosureSEC source: 0001613801-25-000040 · form4-12222025_041201.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,288,728 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $96.25 to $97.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 731 | $97.13 | $71,002.03 |
DisclosureSEC source: 0001613801-25-000038 · form4-12172025_041201.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,292,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $97.03 to $97.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,269 | $96.68 | $412,726.92 |
DisclosureSEC source: 0001613801-25-000038 · form4-12172025_041201.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,293,231 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $96.23 to $96.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 100 | $98.24 | $9,824.00 |
DisclosureSEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,297,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 126 | $97.61 | $12,298.86 |
DisclosureSEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,297,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $97.01 to $97.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 90 | $96.17 | $8,655.30 |
DisclosureSEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,297,726 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $96.15 to $96.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 4,684 | $95.30 | $446,385.20 |
DisclosureSEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,297,816 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $95.00 to $95.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,324 | $92.97 | $309,032.28 |
DisclosureSEC source: 0001613801-25-000035 · form4-12022025_041201.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,302,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $92.53 to $93.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,676 | $92.34 | $154,761.84 |
DisclosureSEC source: 0001613801-25-000035 · form4-12022025_041201.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,305,824 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $91.52 to $92.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 24, 2025 Filed Nov 24, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 886 | $91.01 | $80,634.86 |
DisclosureSEC source: 0001613801-25-000033 · form4-11242025_051103.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,307,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $91.00 to $91.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 24, 2025 Filed Nov 24, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,558 | $90.31 | $321,322.98 |
DisclosureSEC source: 0001613801-25-000033 · form4-11242025_051103.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,308,386 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $90.00 to $90.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 24, 2025 Filed Nov 24, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 556 | $89.67 | $49,856.52 |
DisclosureSEC source: 0001613801-25-000033 · form4-11242025_051103.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,311,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $88.99 to $89.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 17:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,816 | $86.12 | $156,393.92 |
DisclosureSEC source: 0001613801-25-000031 · form4-11192025_121101.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,312,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $85.79 to $86.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 17:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,184 | $85.29 | $271,563.36 |
DisclosureSEC source: 0001613801-25-000031 · form4-11192025_121101.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,314,316 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.80 to $85.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,748 | $85.77 | $235,695.96 |
DisclosureSEC source: 0001613801-25-000028 · form4-11122025_041103.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,317,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $85.29 to $86.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,252 | $84.59 | $190,496.68 |
DisclosureSEC source: 0001613801-25-000028 · form4-11122025_041103.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,320,248 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.27 to $85.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 100 | $84.60 | $8,460.00 |
DisclosureSEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 6 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,322,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,618 | $83.85 | $135,669.30 |
DisclosureSEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,322,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $83.52 to $84.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,335 | $83.22 | $111,098.70 |
DisclosureSEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,324,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $82.58 to $83.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 900 | $81.71 | $73,539.00 |
DisclosureSEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,325,553 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $81.50 to $81.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 601 | $81.28 | $48,849.28 |
DisclosureSEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,326,453 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $80.61 to $81.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.